Clinical Trials in New York State

Showing 8441-8460 of 13,041 trials

Solace Stress Urinary inContinence Control Efficacy and Safety Study

NCT02210273

The SUCCESS Trial is designed to determine whether the Solace Bladder Control System is safe and effective for the treatment of Stress Urinary Incontinence (SUI) in adult females.

Stress Urinary Incontinence

Solace Therapeutics, Inc.221 participantsStarted Aug 2014

Phoenix, Arizona, United States • Tucson, Arizona, United States • Denver, Colorado, United States +17 more locations

COMPLETEDPhase 380 miles

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

NCT00910910

The purpose of this study is to determine the safety and efficacy of lenalidomide as a first line therapy in treating patients with B-cell Chronic Lymphocytic Leukemia. This study will compare the effects (good and bad) of lenalidomide with chlorambucil.

B-Cell Chronic Lymphocytic Leukemia

Celgene450 participantsStarted Oct 2009

Escondido, California, United States • Whittier, California, United States • New Britain, Connecticut, United States +162 more locations

Solace Stress Urinary inContinence Control Efficacy and Safety Study

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Find Trials by Condition in New York State

A Study of Intratumoral CAVATAK™ in Patients With Stage IIIc and Stage IV Malignant Melanoma (VLA-007 CALM )

Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance

Efficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin Lymphomas

A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer

Study of Safety of Elotuzumab Administered Over Approximately 60 Minutes in Combination With Lenalidomide and Dexamethasone for Newly Diagnosed or Relapsed/Refractory Multiple Myeloma Patients

Fetal ST Segment and T Wave Analysis in Labor

Omega-3 Fatty Acid Supplementation to Prevent Preterm Birth in High Risk Pregnancies

Registry for Integrative Medicine Interventions Effectiveness

Continuation Study of the Oral AKT Inhibitor GSK2110183

Standard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the Bone

Investigate Safety, Pharmacokinetics and Pharmacodynamics of GSK2118436 & GSK1120212

Safety and Tolerability Study of 2 Dose Level of Arikayce™ in Patients With Bronchiectasis and Chronic Infection Due to Pseudomonas Aeruginosa.

Radiofrequency Ablation in Treating Patients With Bone Metastases

Two Daily Disposable Contact Lenses in Symptomatic Patients

A Single-dose Study in Paediatric Patients Aged 2 to Less Than 18 Years With Secondary Hyperparathyroidism (sHPT) Receiving Haemodialysis

Sevuparin Infusion for the Management of Acute VOC in Subjects With SCD

Comparative Study of Fluticasone Furoate(FF)/Umeclidinium Bromide (UMEC)/ Vilanterol (VI) Closed Therapy Versus FF/VI Plus UMEC Open Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN)